Medicine & Life Sciences
Cost-Benefit Analysis
100%
Costs and Cost Analysis
47%
Quality-Adjusted Life Years
37%
Systematic Reviews
37%
Randomized Controlled Trials
36%
Glaucoma
31%
Open Angle Glaucoma
23%
Critical Illness
18%
Critical Care
18%
Macular Degeneration
15%
Endometrial Ablation Techniques
15%
Laparoscopy
15%
Bell Palsy
14%
Ocular Hypertension
13%
National Institutes of Health (U.S.)
13%
Menorrhagia
13%
Confidence Intervals
12%
Acyclovir
12%
Eye
12%
Colorectal Neoplasms
12%
Laparoscopic Cholecystectomy
11%
Gallstones
11%
Meta-Analysis
11%
Quality of Life
10%
Central Venous Pressure
10%
Prednisolone
10%
Optical Coherence Tomography
10%
Economics
10%
Hysterectomy
10%
teduglutide
9%
Conservative Treatment
9%
Databases
8%
Eunuchism
8%
Microbial Collagenase
8%
Therapeutics
8%
Pragmatic Clinical Trials
8%
Nurses
7%
Dupuytren Contracture
7%
Hereditary Angioedemas
7%
Short Bowel Syndrome
6%
Fluorescein Angiography
6%
Intraocular Pressure
6%
Mortality
6%
Economic Models
6%
Hypogonadism
6%
Delivery of Health Care
6%
Testosterone
6%
Odds Ratio
6%
Scotland
6%
Uncertainty
6%
Social Sciences
costs
47%
life years
32%
evaluation
29%
economics
27%
surgery
21%
diagnostic study
17%
monitoring
15%
cancer
13%
confidence
13%
surveillance
8%
coherence
8%
diagnostic
8%
uncertainty
7%
health service
6%
aggregate data
6%
hypertension
6%
mortality
6%
quality of life
6%
pain
6%
health
5%
evidence
5%
pragmatics
5%
performance
5%
